Tatiani Oliveira Fereguetti
Overview
Explore the profile of Tatiani Oliveira Fereguetti including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
134
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
de Paiva B, Pereira P, de Andrade C, Gomes V, Souza-Silva M, Martins K, et al.
Sci Rep
. 2023 Mar;
13(1):3463.
PMID: 36859446
The majority of early prediction scores and methods to predict COVID-19 mortality are bound by methodological flaws and technological limitations (e.g., the use of a single prediction model). Our aim...
2.
Souza-Silva M, Ziegelmann P, Nobre V, Gomes V, Beck da Silva Etges A, Schwarzbold A, et al.
Intern Emerg Med
. 2022 Sep;
17(8):2299-2313.
PMID: 36153772
The COVID-19 pandemic caused unprecedented pressure over health care systems worldwide. Hospital-level data that may influence the prognosis in COVID-19 patients still needs to be better investigated. Therefore, this study...
3.
da Silveira W, Ramos L, Silva R, de Paiva B, Pereira P, Schwarzbold A, et al.
Intern Emerg Med
. 2022 Jun;
17(7):1863-1878.
PMID: 35648280
Previous studies that assessed risk factors for venous thromboembolism (VTE) in COVID-19 patients have shown inconsistent results. Our aim was to investigate VTE predictors by both logistic regression (LR) and...
4.
Molina I, Marcolino M, Pires M, Ramos L, Silva R, Guimaraes-Junior M, et al.
Sci Rep
. 2021 Oct;
11(1):20289.
PMID: 34645833
Chagas disease (CD) continues to be a major public health burden in Latina America. Information on the interplay between COVID-19 and CD is lacking. Our aim was to assess clinical...
5.
Cota G, de Sousa M, Fereguetti T, Saleme P, Alvarisa T, Rabello A
PLoS One
. 2016 Feb;
11(2):e0149697.
PMID: 26894430
Introduction: There are few drugs with proven efficacy in cutaneous leishmaniasis (CL), and pentavalent antimonial derivatives are still the main first-line therapeutic agents worldwide, despite their recognized high toxicities. Randomized...
6.
Cota G, de Sousa M, Fereguetti T, Rabello A
PLoS Negl Trop Dis
. 2013 May;
7(5):e2195.
PMID: 23658850
Objective: We conducted a systematic literature review with indirect comparison of studies evaluating therapeutic efficacy and toxicity associated to visceral leishmaniasis (VL) therapy among HIV infected individuals. Main Outcome Measurements:...